Table 4.
Significant Pathways in Integrated Data
| Offset Rank Outlier Results | p-Value |
| KEGG PATHWAYS IN CANCER | < 0.00002 |
| KEGG FOCAL ADHESION | 0.00203 |
| KEGG REGULATION OF THE ACTIN CY-TOSKELETON | 0.00983 |
| KEGG THYROID CANCER | 0.01095 |
| KEGG MELANOGENESIS | 0.01099 |
| KEGG GLIOMA | 0.01317 |
| KEGG MELANOMA | 0.01493 |
| KEGG NEUROTROPHIN SIGNALING PATH-WAY | 0.03523 |
| KEGG NON SMALL CELL LUNG CANCER | 0.04021 |
| KEGG CHRONIC MYELOID LEUKEMIA | 0.04219 |
| KEGG PROTEASOME | 0.04233 |
| BIOCARTA GH PATHWAY | 0.04673 |
| Rank Outlier Results | p-Value |
| KEGG NEUROACTIVE LIGAND RECEPTOR INTERACTION | 0.01356 |
| Tibshirani-Hastie Outlier Results | p-Value |
| KEGG SPLICEOSOME | < 0.00003 |
| KEGG UBIQUITIN MEDIATED PROTEOLYSIS | 0.00228 |
| KEGG ENDOCYTOSIS | 0.00254 |
| KEGG RENAL CELL CARCINOMA | 0.04501 |